Ion chromatography detection and analysis method for cation impurities in adriamycin

Through the ion chromatography detection and analysis method, the problem of cationic impurity detection in doxorubicin is solved, efficient and accurate detection of cationic impurity is achieved, and the production quality and purity of doxorubicin is improved.

CN119023838APending Publication Date: 2024-11-26WUXI FORTUNE PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411158985.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art is difficult to effectively detect and remove cationic impurities in doxorubicin intermediates and final products, affecting their production quality and purity.

Method used

Using ion chromatography detection and analysis method, Dionex IonPacTMCG16 RFICTM was used as the protection column and Dionex IonPacTMCS16 RFICTM was used as the analysis column, combined with Dionex RFC-30 reagent-free controller-methylsulfonic acid leachate, through isometric elution and ion chromatography external standard Quantitative analysis was carried out to prepare blank, control and test sample solutions to achieve efficient detection of cationic impurities.

Benefits of technology

It provides a convenient, fast, accurate and precise cationic impurity detection method, improves detection efficiency, is suitable for batch testing, meets the needs of drug research and development and production, and improves the purity and yield of doxorubicin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119023838A_ABST
    Figure CN119023838A_ABST
Patent Text Reader

Abstract

The invention discloses an ion chromatography detection and analysis method for cation impurities in adriamycin, which comprises the following steps: determining through ion chromatography, and selecting Dionex IonPacTM CG16RFICTM as a guard column; dionex IonPacTM CS16RFICTM is used as an analytical column, and the method comprises the following steps of: taking Dionex The leacheate is a Dionex RFC-30 reagent-free controller-methanesulfonic acid leacheate generator, and isocratic elution is carried out; and carrying out quantitative analysis by adopting an ion chromatography external standard method. The ion chromatography detection and analysis method for the cation impurities in the adriamycin has the advantages of being convenient and rapid to operate, high in accuracy, high in precision and high in specificity. The method is suitable for detection work of doxorubicin and intermediates thereof in a laboratory, batch detection can be carried out, the detection efficiency is improved, and the requirements of research, development and production are met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug analysis, and in particular to an ion chromatography detection and analysis method for cationic impurities in doxorubicin. Background Art

[0002] Doxorubicin, also known as doxorubicin, is a glycoside antitumor antibiotic extracted from the fermentation broth of Streptomyces peucetius var.caesius. Its mechanism of action is to inhibit the proliferation of tumor cells by inhibiting the synthesis of RNA and DNA. It has a wide anti-tumor spectrum and is effective against a variety of tumors. It is a cycle non-specific drug and has a killing effect on tumor cells in various growth cycles. It is mainly suitable for acute leukemia, Hodgkin's and non-Hodgkin's lymphomas, breast cancer, lung cancer, ovarian cancer, soft tissue sarcoma, etc.

[0003] At present, the main industrial production method of doxorubicin is semi-chemical synthesis, that is, the intermediate product daunorubicin obtained by microbial fermentation is used as the raw material, and then seven steps of chemical reaction are required to achieve the introduction of the C-14 hydroxyl group. Various catalysts and reactants need to be added during the entire chemical synthesis process, so that the yield of doxorubicin is not high. Cationic impurities are detected during the synthesis process so that the ionic impurities can be removed in the subsequent reaction to increase the final yield of doxorubicin and improve the purity of doxorubicin.

[0004] In order to ensure the research and development and production quality of doxorubicin and its intermediates, it is particularly urgent for pharmaceutical manufacturers to develop an ion chromatography detection and analysis method for cationic impurities in doxorubicin. Summary of the invention

[0005] The purpose of the present invention is to provide an ion chromatography detection and analysis method for cationic impurities in doxorubicin, which is convenient to operate, rapid, highly accurate, highly precise and highly specific.

[0006] According to one aspect of the present invention, an ion chromatography method for detecting and analyzing cationic impurities in doxorubicin is provided. The method is carried out by ion chromatography, using Dionex IonPac TM CG16 RFIC TM As a guard column; Dionex IonPac TM CS16 RFIC TM As analytical column; the eluent is Dionex RFC-30 reagentless controller-methanesulfonic acid eluent generator, isocratic elution; and the ion chromatography external standard method is used for quantitative analysis;

[0007] The method also includes the preparation of a solution:

[0008] A blank solution, wherein the blank solution consists of a diluent;

[0009] A reference solution, wherein the reference solution is composed of standard solution diluents of magnesium ions, calcium ions, sodium ions, and potassium ions;

[0010] The test solution is composed of the doxorubicin or doxorubicin intermediate and a diluent.

[0011] In some embodiments, the diluent is selected from water, 5% nitric acid solution, or a mixture thereof.

[0012] In some embodiments, the suppressor during detection is AERS (4 mm) or AERS (2 mm).

[0013] In some embodiments, the suppressor is an AERS (4 mm); the suppression current is 88 mA.

[0014] In some embodiments, the diameter of the chromatographic column is 0.5 mm to 5.0 mm, the flow rate of the chromatographic column is 0.5 ml / min to 1.5 ml / min, the column temperature is 35° C. to 45° C., and the injection volume is 25 μL to 40 μL.

[0015] In some embodiments, the diameter of the chromatographic column is 5.0 mm; the flow rate is 0.8 ml / min; the column temperature is 40° C.; and the injection volume is 25 μL.

[0016] In some embodiments, the temperature of the detection cell during use of the conductivity detector during the detection process is 30°C to 40°C.

[0017] Compared with the prior art, the present invention has the following beneficial effects:

[0018] The ion chromatography detection and analysis method for cationic impurities in doxorubicin provided by the present invention has the advantages of convenient operation, rapidity, high accuracy, high precision and strong specificity. It is suitable for laboratory detection of doxorubicin and its intermediates, can be detected in batches, improves detection efficiency, and meets the needs of research and development and production. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Shown is a chromatogram of a blank solution in the present invention;

[0020] Figure 2 Shown is a chromatogram of a reference solution in the present invention;

[0021] Figure 3 Shown is a chromatogram of the test solution in the present invention. DETAILED DESCRIPTION

[0022] The present invention is described in detail below in conjunction with various embodiments, but it should be noted that these embodiments are not limitations of the present invention, and any equivalent transformations or substitutions in functions, methods, or structures made by ordinary technicians in the field based on these embodiments are all within the scope of protection of the present invention.

[0023] In the present disclosure, the term "external standard method" refers to a method of using a pure sample of a component to be measured as a reference substance and comparing the response signals of the reference substance with those of the component to be measured in a sample for quantification.

[0024] In the present invention, the term "blank solution" refers to a solution that is measured under the same conditions as the sample in order to eliminate interference in the HPLC analysis method. The measured result is called the "blank value" and should be deducted from the sample measurement result to improve the accuracy of the measurement.

[0025] In the present invention, the term "test solution" refers to the solution of the sample to be tested in the ion chromatography analysis method.

[0026] In the present invention, the term "reference solution" refers to a solution of a standard sample in an ion chromatography analysis method.

[0027] The present invention provides an ion chromatography detection and analysis method for cationic impurities in doxorubicin. The method is carried out by ion chromatography and Dionex IonPac TM CG16 RFIC TM As a guard column; Dionex IonPac TM CS16 RFIC TM As analytical column; the eluent is Dionex RFC-30 reagentless controller-methanesulfonic acid eluent generator, isocratic elution; and the ion chromatography external standard method is used for quantitative analysis;

[0028] The method also includes the preparation of a solution:

[0029] A blank solution, wherein the blank solution consists of a diluent;

[0030] A reference solution, wherein the reference solution is composed of standard solution diluents of magnesium ions, calcium ions, sodium ions, and potassium ions;

[0031] The test solution is composed of the doxorubicin or doxorubicin intermediate and a diluent.

[0032] Chromatographic conditions of the detection method:

[0033] instrument Thermo ion chromatography Chromatographic columns <![CDATA[Dionex IonPac TM CS16 RFIC TM ,5mm×250mm]]> Guard column <![CDATA[Dionex IonPac TM CG16 RFIC TM ,5mm×50mm]]> Eluent 20 mM methanesulfonic acid Detector Inhibitory conductance Inhibition current 88mA Suppressor AERS(4mm) Flow rate 0.8ml / min Column temperature 40℃; Detection pool temperature 35℃; Injection volume 25 Elution method Isocratic

[0034] Experimental steps:

[0035] Solution preparation: (1) Accurately weigh appropriate amounts of standard solutions (100 μg / ml) of magnesium ions, calcium ions, sodium ions, and potassium ions, and dilute with water to prepare a mixed solution containing approximately 0.3 μg of sodium ions and calcium ions, and 0.1 μg of magnesium ions and potassium ions per 1 ml, as the reference solution. (2) Preparation of test solution: Accurately weigh the doxorubicin test sample, dissolve it in water and dilute it to prepare a solution containing approximately 0.5 mg of doxorubicin per 1 ml, as the test solution.

[0036] Accurately pipette 25 μL of reference solution, blank solution, and test solution, inject them into the ion chromatograph for measurement, and obtain the chromatogram, such as Figure 1 , Figure 2 and Figure 3 shown.

[0037] According to the chromatogram, the content of cationic impurities in doxorubicin was calculated by external standard method.

[0038]

[0039] The results showed that the blank solvent did not interfere with the detection of magnesium, calcium, sodium and potassium ions. In the reference solution, magnesium, calcium, sodium and potassium ions had good separation from adjacent peaks, good peak shape, good peak purity, theoretical plate number greater than 3000, and tailing factor less than 1.5, which met the standards.

[0040] The series of detailed descriptions listed above are only specific descriptions of feasible implementation methods of the present invention. They are not intended to limit the scope of protection of the present invention. Any equivalent implementation methods or changes that do not deviate from the technical spirit of the present invention should be included in the scope of protection of the present invention.

[0041] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. An ion chromatography detection and analysis method for cationic impurities in doxorubicin, characterized in that: The determination was performed by ion chromatography using Dionex IonPac TM CG16 RFIC TM As a guard column; Dionex IonPac TM CS16 RFIC TM As analytical column; the eluent is Dionex RFC-30 reagentless controller-methanesulfonic acid eluent generator, isocratic elution; and the ion chromatography external standard method is used for quantitative analysis; The method also includes the preparation of a solution: A blank solution, wherein the blank solution consists of a diluent; A reference solution, wherein the reference solution is composed of standard solution diluents of magnesium ions, calcium ions, sodium ions, and potassium ions; The test solution is composed of the doxorubicin or doxorubicin intermediate and a diluent.

2. The method according to claim 1, characterized in that: The diluent is selected from water, 5% nitric acid solution or a mixture thereof.

3. The method according to claim 2, characterized in that The suppressor used in the test was AERS (4mm) or AERS (2mm).

4. The method according to claim 3, characterized in that The suppressor is AERS (4 mm); the suppression current is 88 mA.

5. The method according to claim 4, characterized in that The diameter of the chromatographic column is 0.5 mm to 5.0 mm, the flow rate of the chromatographic column is 0.5 ml / min to 1.5 ml / min, the column temperature is 35° C. to 45° C., and the injection volume is 25 μL to 40 μL.

6. The method according to claim 5, characterized in that The diameter of the chromatographic column is 5.0 mm; the flow rate is 0.8 ml / min; the column temperature is 40° C.; and the injection volume is 25 μL.

7. The method according to claim 6, characterized in that The temperature of the detection cell of the conductivity detector during the detection process is 30°C to 40°C.